(19)
(11) EP 3 372 677 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
25.09.2019 Bulletin 2019/39

(45) Mention of the grant of the patent:
21.08.2019 Bulletin 2019/34

(21) Application number: 16861871.8

(22) Date of filing: 05.10.2016
(51) International Patent Classification (IPC): 
C12N 7/02(2006.01)
 C12N 7/00(2006.01)
(86) International application number:
PCT/JP2016/079592
(87) International publication number:
WO 2017/077804 (11.05.2017 Gazette 2017/19)

(54)

METHOD FOR PRODUCING PARVOVIRUS HAVING HIGH INFECTIVITY TITER AND HIGH PURITY

VERFAHREN ZUR HERSTELLUNG EINES PARVOVIRUS MIT HOHEM INFEKTIOSITÄTSTITER UND HOHER REINHEIT

PROCÉDÉ DE PRODUCTION D'UN PARVOVIRUS POSSÉDANT UN TITRE ÉLEVÉ D'INFECTIVITÉ ET UNE GRANDE PURETÉ

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 06.11.2015 JP 2015218775

(43) Date of publication of application:
12.09.2018 Bulletin 2018/37

(73) Proprietor: Asahi Kasei Medical Co., Ltd.
Tokyo 100-0006 (JP)

(72) Inventors:
  • SAWAMURA, Yoshiyuki
    Tokyo 101-8101 (JP)
  • YANAGIDA, Koichiro
    Tokyo 101-8101 (JP)

(74) Representative: dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB 
Deichmannhaus am Dom Bahnhofsvorplatz 1
50667 Köln
50667 Köln (DE)


(56) References cited: : 
WO-A1-2014/080676
JP-A- 2015 126 757
 JP-A- H1 132 757
   
  • ASHLEY SLOCUM ET AL: "Impact of virus preparation quality on parvovirus filter performance", BIOTECHNOLOGY AND BIOENGINEERING, vol. 110, no. 1, 6 August 2012 (2012-08-06), pages 229-239, XP055214902, ISSN: 0006-3592, DOI: 10.1002/bit.24600
  • AVALOSSE B ET AL: "METHOD FOR CONCENTRATING AND PURIFYING RECOMBINANT AUTONOMOUS PARVOVIRUS VECTORS DESIGNED FOR TUMOUR-CELL-TARGETED GENE THERAPY", JOURNAL OF VIROLOGICAL METHODS, ELSEVIER BV, NL, vol. 62, no. 2, 1 December 1996 (1996-12-01), pages 179-183, XP001000372, ISSN: 0166-0934, DOI: 10.1016/S0166-0934(96)02105-2
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).